Multiply Labs

Multiply Labs specializes in robotic systems for the manufacturing of precision medicines, particularly in cell therapy. Their technology integrates with GMP instruments, offering modular flexibility and high-throughput capabilities. The systems are designed for industrial-scale production of gene-modified cell therapies, ensuring compliance with regulatory standards while optimizing efficiency in biomanufacturing processes.

Share
Multiply Labs
1426 Minnesota Street
San Francisco, California 94107
RobotToday Initiative

Robotics needs a service framework.

RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.

Share

Related Content

Digital Twin, Physical AI & Robot OEM Readiness 2026: Platforms, VLA Models, LLM Programming

Digital Twin, Physical AI & Robot OEM Readiness 2026: Platforms, VLA Models, LLM Programming

A balanced analysis of the robot intelligence revolution: multi-vendor digital twin platforms (NVIDIA, Siemens, Dassault, ABB, Rockwell, Hexagon), Physical AI VLA models (RT-2, pi0, GR00T N1, AgiBot), current Physical AI limitations, LLM robot programming, and the OEM readiness matrix across US, European, and Chinese manufacturers.

Integrated Joint Actuators 2026: Technology, Global Suppliers & China's Leap Forward

Integrated Joint Actuators 2026: Technology, Global Suppliers & China's Leap Forward

From rotary joints hitting 530 N·m+ to linear joints with planetary roller screws, integrated actuators are replacing the three-part drivetrain. Full supplier map: Tihu, PhyArc, RobStride, Schaeffler, maxon — and China's path from 1,000-RMB modules to global standard-setter.

Laboratory Robotics in 2026: Technology, Companies & Vertical Maturity

Laboratory Robotics in 2026: Technology, Companies & Vertical Maturity

From clinical diagnostics to self-driving labs: a deep analysis of laboratory robotics technologies, mass-production maturity timelines across 12 vertical sectors, 26 key companies, and the investment landscape shaping lab automation through 2030.

Agricultural Robotics: Crop Monitoring and Aerial Scouting

Agricultural Robotics: Crop Monitoring and Aerial Scouting

An evidence-based deep dive into the crop monitoring and aerial scouting segment of agricultural robotics. Covers the market opportunity (ex-China) across North America, EU, Japan, and Israel; key players including Taranis, BASF xarvio, and DJI; emerging technologies such as edge AI, hyperspectral imaging, and satellite–drone fusion; and the structural challenges limiting wider adoption — connectivity gaps, false positives, data fragmentation, and small-farm exclusion.

RoboMME Benchmark Reveals a Critical Weakness in Robot AI: Memory

RoboMME Benchmark Reveals a Critical Weakness in Robot AI: Memory

A new RoboMME benchmark study reveals that modern robot AI still struggles with memory — an emerging bottleneck for generalist and humanoid robotics.

The OpenClaw Test: Which Humanoid Robotics Companies Will Survive 2026?

The OpenClaw Test: Which Humanoid Robotics Companies Will Survive 2026?

How OpenClaw's AI agent orchestration exposes which humanoid robotics companies have genuine hardware innovation vs. expensive commodity robots with proprietary software.

Where Engineers Can Enter Robotics in 2026

Where Engineers Can Enter Robotics in 2026

Robotics hiring in 2026 is driven by deployment, integration, and operations—not hype. A structural map of real entry points for engineers.

AI’s Next Revolution: Multiply Labs Is Scaling Robotics-Driven Cell Therapy Biomanufacturing Labs

AI’s Next Revolution: Multiply Labs Is Scaling Robotics-Driven Cell Therapy Biomanufacturing Labs

A startup is collaborating with prominent cell therapy companies to revolutionize the manufacturing process within clean rooms by integrating robotics technology. This innovative approach is set to significantly lower production costs by over 70% and enhance output efficiency compared to traditional manufacturing systems. The initiative aims to address the growing demand for cell therapies, which require precise and sterile environments for production. By leveraging advanced robotics, the startup is not only streamlining operations but also positioning itself as a key player in the rapidly evolving biotechnology sector. This development is particularly timely, as the industry seeks to meet increasing patient needs while maintaining high-quality standards in cell therapy manufacturing.

How Mimic Robotics is Bringing Physical AI to Dexterous Manipulation

How Mimic Robotics is Bringing Physical AI to Dexterous Manipulation

Mimic Robotics combines dexterous robotic hands with foundation-model Physical AI to automate human-like manipulation tasks in industry with scalable learning.

Who Will Build Foxconn's Humanoids for its Texas AI Factory

Who Will Build Foxconn's Humanoids for its Texas AI Factory

A look at the leading candidates — such as Apptronik, Figure AI, and Agility Robotics — poised to supply humanoid robots for Foxconn’s Texas AI server plant powered by NVIDIA.

Leju Robot Rebrands as Leju Intelligence, Eyes IPO With Strategic Overhaul

Leju Robot Rebrands as Leju Intelligence, Eyes IPO With Strategic Overhaul

Leju Robot rebrands as Leju Intelligence, signaling a strategic shift toward scalable humanoid robotics and a clearer IPO-focused business structure.